Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.

Sabina A GulerJoanne M KwanJanice M LeungNasreen KhalilPearce G WilcoxChristopher J Ryerson

Published in: The European respiratory journal (2020)

Functional ageing is associated with adverse health outcomes in patients with fibrotic ILD, indicating the need for consideration of the individual functional age into clinical decision-making.

Keyphrases

interstitial lung disease
systemic sclerosis
idiopathic pulmonary fibrosis
decision making
rheumatoid arthritis
adverse drug